Clinical Trials Insight: 700045741
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2009
At a glance
- Drugs Daclizumab; Rindopepimut; Temozolomide
- Indications Glioblastoma
- Focus Pharmacodynamics; Therapeutic Use
- 09 Jun 2009 New trial record.
- 31 May 2009 Preliminary data were presented in a poster session at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), according to a Pfizer media release.